Amneal Pharmaceuticals, Inc. (AMRX)
13.24
-0.02
(-0.15%)
USD |
NASDAQ |
Mar 06, 16:00
13.24
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals SG&A Expense (TTM) : 526.83M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.79B |
| Corcept Therapeutics, Inc. | 448.72M |
| Apellis Pharmaceuticals, Inc. | 550.26M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| BioMarin Pharmaceutical, Inc. | 1.153B |